Candel Therapeutics (CADL) Change in Account Payables: 2020-2024
Historic Change in Account Payables for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to -$185,000.
- Candel Therapeutics' Change in Account Payables rose 131.62% to $172,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $45,000, marking a year-over-year increase of 103.71%. This contributed to the annual value of -$185,000 for FY2024, which is 511.11% down from last year.
- As of FY2024, Candel Therapeutics' Change in Account Payables stood at -$185,000, which was down 511.11% from $45,000 recorded in FY2023.
- In the past 5 years, Candel Therapeutics' Change in Account Payables ranged from a high of $669,000 in FY2021 and a low of -$1.2 million during FY2022.
- Its 3-year average for Change in Account Payables is -$451,000, with a median of -$185,000 in 2024.
- As far as peak fluctuations go, Candel Therapeutics' Change in Account Payables spiked by 131.49% in 2021, and later plummeted by 511.11% in 2024.
- Candel Therapeutics' Change in Account Payables (Yearly) stood at $289,000 in 2020, then soared by 131.49% to $669,000 in 2021, then slumped by 281.32% to -$1.2 million in 2022, then soared by 103.71% to $45,000 in 2023, then slumped by 511.11% to -$185,000 in 2024.